March 3, 2008, Claraview, Inc. was acquired by Teradata Corporation (NYSE: TDC). Claraview is a leading strategy and technology consultancy that helps companies and government agencies use business intelligence to achieve competitive advantage and operational excellence. Teradata Corporation is the global leader in data warehousing and analytic technologies. Outcome Capital acted as financial advisor to Claraview on this transaction.
Sid Banerjee, Founder and CEO of Claraview, commented, “When we started Claraview seven years ago, we set out to build a world class professional services organization with people singularly dedicated to planning, designing, and implementing complex business intelligence and data warehousing solutions for our corporate and government clients. Like Claraview, Teradata is focused on data warehousing, and Claraview’s business intelligence expertise greatly complements Teradata’s solutions. The combination of Teradata and Claraview is a terrific outcome for our people who are dedicated to continuing our leadership in the world of business intelligence and data analytics as part of Teradata.”
Terms of the transaction are undisclosed.
About Claraview, Inc.
Claraview is an industry leader in implementing business intelligence solutions that enable organizations to more efficiently analyze data and make better business decisions. Claraview is 100% focused on business intelligence and data warehousing and is staffed with experts in all facets of BI/DW system deployment.
About Teradata Corporation
Teradata Corporation is the global leader in data warehousing and analytic technologies. Teradata offers a robust and innovative portfolio of horizontal and industry analytical applications for data warehousing, customer management, finance and performance management, and demand and supply chain analysis and management. Teradata delivers integrated, enterprise-scale analytical solutions based on the most powerful, scalable and reliable technology platform in the industry.
– Advisory Services Practice to Assist Growth-Stage Life Science Companies in Pre-Transaction Preparation and Strategic Corporate Development – August 24, 2022 08:30 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–Outcome Capital, a highly specialized life science and healthcare investment banking group, today announced the formal launch of an Advisory Services Practice in response to demand from client […]Read More
Outcome Capital Life Science Market Pulse October 2022 Click to view our LifeSciences Pulse NewsletterDownload